Katherine A. Guthrie

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

Also affiliated with Fred Hutch Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.2Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Toward a better measure of midlife sexual function: pooled analyses in nearly 1,000 women participating in MsFLASH randomized trials

Menopause The Journal of The North American Menopause Society(2022)10.1097/gme.0000000000001940

Top 29%

0.692DataRank

Top 29%11 citations

Janet S. Carpenter, Joseph Larson, Caroline M. Mitchell, Jan Shifren, Julia Heiman +5 more

Papers

Driven by 47 papers — median percentile 65. Top paper: “Association between postmenopausal vulvovaginal discomfort, vaginal microbiota, and mucosal inflammation”.

Association between postmenopausal vulvovaginal discomfort, vaginal microbiota, and mucosal inflammation

American Journal of Obstetrics and Gynecology(2021)10.1016/j.ajog.2021.02.034

N/A

1.8DataRank · unranked

58 citations

Nanxun Ma, Alissa J. Mitchell, Michael C. Wu, Daniel Valint, Sean Proll +9 more

Impact of Topical Interventions on the Vaginal Microbiota and Metabolome in Postmenopausal Women

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.5032

N/A

1.3DataRank · unranked

32 citations

Xing Hua, Michael C. Wu, Sean Proll, D. J. Valint, Susan D. Reed +9 more

SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers

Journal of Clinical Oncology(2024)10.1200/jco-24-01383

N/A

1.1DataRank · unranked

51 citations

Gentry Teng King, Sarah Colby, Aaron J. Scott, Mitesh J. Borad, Laura W. Goff +17 more

Association of Vaginal Estradiol Tablet With Serum Estrogen Levels in Women Who Are Postmenopausal

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.41743

N/A

1.0DataRank · unranked

26 citations

Joseph C. Larson, Carolyn Crandall, Shalender Bhasin, Andrea Z. LaCroix, Kristine E. Ensrud +3 more

The complexity of genitourinary syndrome of menopause: number, severity, and frequency of vulvovaginal discomfort symptoms in women enrolled in a randomized trial evaluating treatment for genitourinary syndrome of menopause

Menopause The Journal of The North American Menopause Society(2023)10.1097/gme.0000000000002212

N/A

0.863DataRank · unranked

22 citations

Joseph C. Larson, Susan D. Reed, Katherine A. Guthrie, Caroline M. Mitchell

SWOG S1505: Results of perioperative chemotherapy (peri-op CTx) with mfolfirinox versus gemcitabine/nab-paclitaxel (Gem/nabP) for resectable pancreatic ductal adenocarcinoma (PDA).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4504

N/A

0.713DataRank · unranked

115 citations

Mai T. Duong, Syed A. Ahmad, Namita Gandhi, Muhammad Shaalan Beg, Andrea Wang‐Gillam +7 more

Toward a better measure of midlife sexual function: pooled analyses in nearly 1,000 women participating in MsFLASH randomized trials

Menopause The Journal of The North American Menopause Society(2022)10.1097/gme.0000000000001940

Top 29%

0.692DataRank

Top 29%11 citations

Janet S. Carpenter, Joseph Larson, Caroline M. Mitchell, Jan Shifren, Julia Heiman +5 more

Comparison of the Vaginal Microbiota in Postmenopausal Black and White Women

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa780

N/A

0.635DataRank · unranked

16 citations

Wodan Ling, Michael C. Wu, Matthew R. Hayward, Alissa J. Mitchell, Joseph C. Larson +5 more

Randomized Phase II Study of PARP Inhibitor ABT-888 (Veliparib) with Modified FOLFIRI versus FOLFIRI as Second-line Treatment of Metastatic Pancreatic Cancer: SWOG S1513

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1789

N/A

0.601DataRank · unranked

54 citations

Katherine A. Guthrie, Philip A. Philip, Elizabeth M. Swisher, Florencia G. Jalikis, Michael J. Pishvaian +11 more

Randomised phase II trial (SWOG S1310) of single agent MEK inhibitor trametinib Versus 5-fluorouracil or capecitabine in refractory advanced biliary cancer

European Journal of Cancer(2020)10.1016/j.ejca.2020.01.026

N/A

0.568DataRank · unranked

43 citations

Shannon McDonough, Anthony B. El-Khoueiry, Tanios Bekaii‐Saab, Stacey Stein, Vaibhav Sahai +9 more

SWOG S1820: Altering Intake, Managing Symptoms for bowel dysfunction in survivors of Rectal Cancer (The AIMS-RC intervention trial)

Contemporary Clinical Trials Communications(2021)10.1016/j.conctc.2021.100768

Top 41%

0.466DataRank

Top 41%8 citations

Tracy E. Crane, Kathryn B. Arnold, Katherine A. Guthrie, Sarah Freylersythe, Christa Braun‐Inglis +6 more

Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With RAS/BRAF Wild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial

Journal of Clinical Oncology(2025)10.1200/jco-24-01710

N/A

0.458DataRank · unranked

9 citations

Katherine A. Guthrie, Benjamin Tan, Crystal S. Denlinger, Marwan Fakih, Michael J. Overman +15 more

Randomized phase II trial of olaparib + pembrolizumab versus olaparib alone as maintenance therapy in metastatic pancreatic cancer patients with germline BRCA1 or BRCA2 (gBRCA1/2+) mutations: SWOG S2001.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.tps447

N/A

0.396DataRank · unranked

13 citations

Katherine A. Guthrie, Michael J. Pishvaian, Andrew M. Lowy, E. Gabriela Chiorean, Mai T. Duong +3 more

Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance)

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0447

N/A

0.360DataRank · unranked

10 citations

Chao Ma, Chen Yuan, Qian Shi, Brian M. Wolpin, Yin Zhang +19 more

Association between vaginal microbiota and vaginal inflammatory immune markers in postmenopausal women

Menopause The Journal of The North American Menopause Society(2024)10.1097/gme.0000000000002362

N/A

0.330DataRank · unranked

8 citations

Hoseung Song, Sujatha Srinivasan, David N. Fredricks, Susan D. Reed, Katherine A. Guthrie +3 more

NRG-GI004/SWOG-S1610: Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study—A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.tps158

N/A

0.241DataRank · unranked

4 citations

Greg Yothers, Samuel A. Jacobs, Hanna K. Sanoff, Deirdre Jill Cohen, Katherine A. Guthrie +10 more

A randomized phase III study of mFOLFOX6/bevacizumab combination chemotherapy with or without atezolizumab or atezolizumab monotherapy in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) metastatic colorectal cancer (mCRC): Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) study (NRG-GI004/SWOG-S1610).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.tps260

N/A

0.241DataRank · unranked

4 citations

Greg Yothers, Samuel A. Jacobs, Hanna K. Sanoff, Deirdre Jill Cohen, Katherine A. Guthrie +10 more

NRG-GI004/SWOG-S1610: Colorectal cancer metastatic dMMR immuno-therapy (COMMIT) study—A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.tps232

N/A

0.241DataRank · unranked

4 citations

Greg Yothers, Samuel A. Jacobs, Hanna K. Sanoff, Deirdre Jill Cohen, Katherine A. Guthrie +10 more

Celecoxib in addition to standard adjuvant therapy with 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX) in stage III colon cancer: Results from CALGB/SWOG 80702.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4003

N/A

0.217DataRank · unranked

3 citations

Qian Shi, Charles S. Fuchs, Donna Niedzwiecki, Tyler Zemla, Priya Kumthekar +15 more

S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)

Future Oncology(2025)10.1080/14796694.2025.2485020

N/A

0.176DataRank · unranked

2 citations

Sarah Colby, Paul E. Oberstein, Dan G. Duda, Robin Park, Rajiv Agarwal +12 more

Positive impact of a menopause website – MyMenoplan.org – on treatment intentions, knowledge, and decision making: A randomized controlled trial

Maturitas(2025)10.1016/j.maturitas.2025.108630

N/A

0.165DataRank · unranked

2 citations

Katherine M. Newton, Ho‐Keung Ng, Susan D. Reed, Katherine A. Guthrie, Viviana Paola Patiño Zambrano +2 more

The Vanguard study: An NCI cancer screening research network multi-cancer detection feasibility study.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.e22522

N/A

0.165DataRank · unranked

2 citations

Katherine A. Guthrie, Yikyung Park, Quyen Ngo‐Metzger, Rebecca Kaltman, Carrie B. Lee +4 more

SWOG S1820: A pilot randomized trial of the Altering Intake, Managing Bowel Symptoms Intervention in Survivors of Rectal Cancer

Cancer(2024)10.1002/cncr.35264

N/A

0DataRank · unranked

7 citations

Katherine A. Guthrie, Tracy E. Crane, Kathryn B. Arnold, Sarah Colby, Sarah Freylersythe +14 more

Intratumoral Cell Neighborhoods Coordinate Outcomes in Pancreatic Ductal Adenocarcinoma

Gastroenterology(2024)10.1053/j.gastro.2024.01.013

N/A

0DataRank · unranked

18 citations

Sarah Colby, Ignacio Garrido‐Laguna, Yuqing Xue, Renee B. Chang, Devora Delman +14 more

Chemotherapy dose density is prognostic for overall survival in patients with resectable pancreas cancer: A landmark analysis of SWOG 1505

Cancer(2025)10.1002/cncr.35759

N/A

0DataRank · unranked

2 citations

Sarah Colby, Davendra Sohal, Katherine A. Guthrie, Lisa A. Kachnic, E. Gabriela Chiorean +6 more

Cook and Move for Your Life, an eHealth intervention for women with breast cancer

npj Breast Cancer(2024)10.1038/s41523-024-00662-2

N/A

0DataRank · unranked

2 citations

Eileen Rillamas‐Sun, Rachel L. Yung, Sofia Cobos, Sidney M. Donzella, Yuhan Huang +12 more

Bacterial Communities Associated With Abnormal Nugent Score in Postmenopausal Versus Premenopausal Women

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa675

N/A

0DataRank · unranked

15 citations

Sujatha Srinivasan, Nanxun Ma, Susan D. Reed, Michael C. Wu, Noah G. Hoffman +7 more

Patient-centered change in the day-to-day impact of postmenopausal vaginal symptoms: results from a multicenter randomized trial

American Journal of Obstetrics and Gynecology(2020)10.1016/j.ajog.2019.12.270

N/A

0DataRank · unranked

14 citations

Alison J. Huang, Joseph C. Larson, Caroline M. Mitchell, Susan J. Diem, Andrea Z. LaCroix +4 more

The association of patient fatigue and outcomes in advanced cancer: An analysis of four SWOG treatment trials.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.29_suppl.140

N/A

0DataRank · unranked

0 citations

Amy K. Darke, Katherine A. Guthrie, Jeff A. Sloan, Joseph M. Unger, Dawn L. Hershman +4 more

Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study: A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC)—NRG-GI004/SWOG-S1610.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps3618

N/A

0DataRank · unranked

7 citations

Greg Yothers, Samuel A. Jacobs, Hanna K. Sanoff, Deirdre Jill Cohen, Katherine A. Guthrie +10 more

Immunologic predictors of therapeutic response to neoadjuvant chemotherapy for pancreatic ductal adenocarcinoma (PDA) in SWOG S1505.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.419

N/A

0DataRank · unranked

2 citations

Mai T. Duong, Renee B. Chang, Yuqing Xue, Devora Delman, Ignacio Garrido‐Laguna +15 more

Body composition measurements and overall survival in patients with resectable pancreatic adenocarcinoma receiving neoadjuvant chemotherapy: Analysis from SWOG S1505.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4131

N/A

0DataRank · unranked

0 citations

Mai T. Duong, Robert D. Boutin, Leon Lenchik, Jiyoon Kim, Namita Gandhi +11 more

Does adjuvant chemoradiation benefit patients with lymph node-positive biliary tract cancer? A secondary analysis of SWOG S0809.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4104

N/A

0DataRank · unranked

0 citations

Mai T. Duong, David P. Horowitz, Katherine A. Guthrie, Edgar Ben‐Josef, Anthony B. El-Khoueiry +5 more

A digital health intervention to improve nutrition and physical activity in breast cancer survivors: Rationale and design of the Cook and Move for Your Life pilot and feasibility randomized controlled trial

Contemporary Clinical Trials(2022)10.1016/j.cct.2022.106993

N/A

0DataRank · unranked

16 citations

Sofia Cobos Sanchez, Eileen Rillamas‐Sun, Hanjie Shen, Liza Schattenkerk, Gino Garcia +10 more

Randomized phase II trial of postoperative adjuvant capecitabine and temozolomide versus observation in high-risk pancreatic neuroendocrine tumors: SWOG S2104.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.tps515

N/A

0DataRank · unranked

9 citations

Katherine A. Guthrie, Syed A. Ahmad, M. Kay Washington, Brian Hemendra Ramnaraign, Nitya Raj +8 more

Colorectal cancer metastatic dMMR immuno-therapy (COMMIT) study: A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC)—NRG-GI004/SWOG-S1610.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps3647

N/A

0DataRank · unranked

4 citations

Greg Yothers, Samuel A. Jacobs, Hanna K. Sanoff, Deirdre Jill Cohen, Katherine A. Guthrie +11 more

Randomized phase II selection study of ramucirumab and paclitaxel versus FOLFIRI in refractory small bowel adenocarcinoma: SWOG S1922.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.4_suppl.tps643

N/A

0DataRank · unranked

2 citations

Katherine A. Guthrie, Mohamed E. Salem, Katrina S. Pedersen, Aparna Kalyan, Shay Bellasea +2 more

SWOG 1815: A phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.lba490

N/A

0DataRank · unranked

99 citations

Katherine A. Guthrie, Aaron J. Scott, Mitesh J. Borad, Laura W. Goff, Khalid Matin +15 more

Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809)

Annals of Surgical Oncology(2023)10.1245/s10434-022-12863-9

N/A

0DataRank · unranked

13 citations

Sarah Colby, David P. Horowitz, Katherine A. Guthrie, Edgar Ben‐Josef, Anthony B. El-Khoueiry +6 more

Randomized phase II trial of encorafenib and cetuximab with or without nivolumab for patients with previously treated, microsatellite stable, BRAFV600E metastatic and/or unresectable colorectal cancer: SWOG S2107.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps265

N/A

0DataRank · unranked

8 citations

Katherine A. Guthrie, Scott Kopetz, Rimini Breakstone, Thomas B. Karasic, Zishuo Ian Hu +6 more

A randomized phase 2 study of trastuzumab and pertuzumab (TP) compared to cetuximab and irinotecan (CETIRI) in advanced/metastatic colorectal cancer (mCRC) with HER2 amplification: SWOG S1613.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.140

N/A

0DataRank · unranked

7 citations

Katherine A. Guthrie, Scott Kopetz, Benjamin Tan, Crystal S. Denlinger, Marwan Fakih +15 more

Randomized phase II trial of olaparib + pembrolizumab vs olaparib alone as maintenance therapy in metastatic pancreatic cancer patients with germline BRCA1 or BRCA2 (gBRCA1/2+) pathogenic variants: SWOG S2001.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps4198

N/A

0DataRank · unranked

6 citations

Katherine A. Guthrie, Michael J. Pishvaian, Kim Anna Reiss, Andrew M. Lowy, Davendra Sohal +7 more

P-228 Randomized phase II trial of encorafenib and cetuximab with or without nivolumab for patients with previously treated, microsatellite stable, BRAFV600E metastatic and/or unresectable colorectal cancer: SWOG S2107

Annals of Oncology(2023)10.1016/j.annonc.2023.04.284

N/A

0DataRank · unranked

2 citations

Katherine A. Guthrie, Scott Kopetz, Rimini Breakstone, Thomas B. Karasic, Zelan Hu +7 more

Randomized, phase II selection study of ramucirumab and paclitaxel versus FOLFIRI in refractory small bowel adenocarcinoma: SWOG S1922.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps784

N/A

0DataRank · unranked

1 citations

Katherine A. Guthrie, Mohamed E. Salem, Katrina S. Pedersen, Aparna Kalyan, Sarah Colby +7 more

NRG-GI004/SWOG-S1610: Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) study—A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability high (MSI-H) metastatic colorectal cancer (mCRC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps258

N/A

0DataRank · unranked

1 citations

Greg Yothers, Samuel A. Jacobs, Hanna K. Sanoff, Deirdre Jill Cohen, Katherine A. Guthrie +11 more

Data from Randomized Phase II Study of PARP Inhibitor ABT-888 (Veliparib) with Modified FOLFIRI versus FOLFIRI as Second-line Treatment of Metastatic Pancreatic Cancer: SWOG S1513

(2023)10.1158/1078-0432.c.6531176

N/A

0DataRank · unranked

0 citations

Katherine A. Guthrie, Philip A. Philip, Elizabeth M. Swisher, Florencia G. Jalikis, Michael J. Pishvaian +11 more

Data from Randomized Phase II Study of PARP Inhibitor ABT-888 (Veliparib) with Modified FOLFIRI versus FOLFIRI as Second-line Treatment of Metastatic Pancreatic Cancer: SWOG S1513

(2023)10.1158/1078-0432.c.6531176.v1

N/A

0DataRank · unranked

0 citations

Katherine A. Guthrie, Philip A. Philip, Elizabeth M. Swisher, Florencia G. Jalikis, Michael J. Pishvaian +11 more

Katherine A. Guthrie

Indexed papers

Top data-sharing exemplar

Papers